https://www.selleckchem.com/pr....oducts/hexamethonium
Three potential molecules (Z126202570, Z46489368, and Z422255982) exhibited promising stable binding interactions with the target. In conclusion, these findings empower further in vitro and clinical assessment for these compounds as novel anti-COVID19 agents.[This corrects the article DOI 10.1016/j.jpra.2018.12.006.][This corrects the article DOI 10.1016/j.jpra.2018.08.001.][This corrects the article DOI 10.1016/j.jpra.2020.10.002.][This corrects the article DOI 10.1016/j.jpra.2020.06.005.][This corrects the article DOI 10
Like
Comment
Share
